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Abstract Herpes simplex virus 1 and 2 (HSV-1 and HSV-2), also known as Human herpes virus 1 and 2 are two members of 
the herpes virus family, Herpesviridae, that infect humans. Both HSV-1 (which produces most cold sores) and HSV-2 (which 
produces most genital herpes) are ubiquitous and contagious. They can be spread when an infected person is producing and 
shedding the virus. The present study was carried out to determine the effect of alcoholic extract of two herbs Eucalyptus globulus 
and Artemisia draconculus on herpes virus compare with acyclovir in Iran during 2011. After preliminary survey, two herbs 
Eucalyptus globulus and Artemisia draconculus were selected as a drug for the treatment of herpes virus. HSV-1 was isolated 
from patients and identified by specific monoclonal antibodies. Vero cells (African green monkey kidney cells) were cultured with 
Dulbecco’s Modified Eagles’ Medium (DMEM) supplemented with 10% heat inactivated Fetal Bovine Serum (FBS), 100 IV/mL 
penicillin and l μg/mL streptomycin. Finally, the effect of these plants and Acyclovir compared with together on herpes virus . 
Results showed Artemisia draconculus could not reduce viral plaques significantly, however methanolic extracts of Eucalyptus 
globulus had a significant inhibitory effect against HSV-1 and concentration (200, 150, 50 μg/mL) has the best effect and (>200 
μg/mL) Has lowest effect on HSV-1.The comparison of results exhibited that Eucalyptus globulus extract has more effects in 
different dilutions against HSV-1 in cell culture. 
Keywords Herpes Virus; Eucalyptus globulus; Artemisia draconculus; Acyclovir 
Background 
The structure of herpes viruses consists of a relatively 
large double-stranded, linear DNA genome encased 
within an icosahedra protein cage called the capsid, 
which is wrapped in a lipid bilayer called the envelope 
(Roller et al., 2008). The envelope is joined to the 
capsid by means of a tegument. This complete particle 
is known as the virion. HSV-1 and HSV-2 each contain 
at least 74 genes (or open reading frames, ORFs) 
within their genomes, although speculation over gene 
crowding allows as many as 84 unique protein coding 
genes by 94 putative ORFs (Yang et al., 2012). These 
genes encode a variety of proteins involved in forming 
the capsid, tegument and envelope of the virus, as 
well as controlling the replication and infectivity of 
the virus (Xu et al., 1999). These genes and their 
functions are summarized in the table below. Cold 
sores, sometimes called fever blisters, are groups of 
small blisters on the lip and around the mouth. The 
skin around the blisters is often red, swollen, and sore. 
The blisters may break open, leak a clear fluid, and 
then scab over after a few days. They usually heal in 
several days to 2 weeks (Chuanasa et al., 2008). Cold 
sores are caused by the herpes simplex virus (HSV). 
There are two types of herpes simplex virus: HSV-1 
and HSV-2. Both virus types can cause sores around 
the mouth (herpes labialis) and on the genitals (genital 
herpes) (Fatahzadeh and Schwartz, 2007).The herpes 
simplex virus usually enters the body through a break 
in the skin around or inside the mouth. It is usually 
spread when a person touches a cold sore or touches 
infected fluid-such as from sharing eating utensils or 
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razors, kissing an infected person, or touching that 
person's saliva (Friedman, 2006). A parent who has a 
cold sore often spreads the infection to his or her child 
in this way. Cold sores can also be spread to other 
areas of the body. The first symptoms of cold sores 
may include pain around your mouth and on your lips, 
a fever, a sore throat, or swollen glands in your neck 
or other parts of the body. Small children sometimes 
drool before cold sores appear (Gershon et al., 2010). 
After the blisters appear, the cold sores usually break 
open, leak a clear fluid, and then crust over and 
disappear after several days to 2 weeks. For some 
people, cold sores can be very painful. Cold sores will 
usually start to heal on their own within a few days. 
But if they cause pain or make you feel embarrassed, 
they can be treated. Treatment may include skin 
creams, ointments, or sometimes pills (Carson et al., 
2008). Treatment may get rid of the cold sores only 1 
to 2 days faster, but it can also help ease painful 
blisters or other uncomfortable symptoms. The herpes 
simplex virus that causes cold sores cannot be cured. 
After you get infected, the virus stays in your body for 
the rest of your life (Chuanasa et al., 2008). Docosanol, 
a saturated fatty alcohol, is a safe and effective topical 
application that has been approved by the United 
States Food and Drug Administration for herpes 
labialis in adults with properly functioning immune 
systems. It is comparable in effectiveness to prescription 
topical antiviral agents. Due to its mechanism of 
action, there is little risk of drug resistance (El Sayed, 
2000). The duration of symptoms can be reduced by 
a small amount if an antiviral, anaesthetic or non- 
treatment cream (such as zinc oxide or zinc sulfate) is 
applied promptly (Chattopadhyay and Khan, 2008). 
Effective antiviral medications include acyclovir and 
penciclovir, which can speed healing by as much as 
10%. Famcyclovir or valacyclovir, taken in pill 
form, can be effective using a single day, high-dose 
application and is more cost effective and convenient 
than the traditional treatment of lower doses for 5~7 
days (Garozzo et al., 2011). Lysine has been suggested 
as a treatment for herpes labialis based on in vitro 
studies, but the evidence is inconclusive in humans 
(Gebre-Mariam et al., 2006). Herpes simplex virus 
(HSV) infections are efficiently treated with antiviral 
drugs such as acyclovir (ACV). However, resistance 
has been reported, mainly among immunocompromi- 
sed patients (prevalence around 5%) and particularly 
allogeneic bone marrow transplant patients (prevalence 
reaching 30%) (Hammer et al., 2006). Resistance to 
ACV is associated with mutations on one of the two 
viral enzymes involved in the ACV mechanism of 
action: thymidine kinase (TK) and DNA polymerase. 
In 95% of the cases, ACV resistance is associated with 
a mutation in the TK gene as this enzyme is not 
essential for viral replication, unlike viral DNA 
polymerase, which is rarely involved in resistance 
(Hosono et al., 2008). Today, some of the herbal 
extracts used in the treatment of herpes sores. In this 
study the influence of alcoholic extract of the herb 
tarragon and eucalyptus compared with the drug 
acyclovir is reviewed. 
1 Results 
Trypan blue exclusion method showed that the 
Eucalyptus globulus and Artemisia draconculus extract 
had no serious effect on the proliferation of cells, up 
to concentration of 800 μg/mL (data not shown). 
Therefore, we could draw a conclusion that the CC50 
(the concentration which causes 50% cytotoxicity 
effect) was more than 800 μg/mL. 
Antiviral activity of the extract by TCID50 assay the 
inhibition of virus yield by Eucalyptus globulus and 
Artemisia draconculus extract was evaluated by 
TCID50 assay in Vero cells. Eucalyptus globulus 
extract showed strong antiviral activity against HSV-1 
when added during the early stages of viral infection. 
The degree of inhibition showed to be proportional 
to the concentration of the extract and when the 
concentration was higher than 200 μg/mL Eucalyptus 
globulus extract inhibited almost completely the virus 
yield. The EC50 value of the extract when treated 
during infection was 650 μg/mL and when treated 
after infection the EC50 decreased to 200 μg/mL, then 
the extract was more effective at low concentrations 
when present after viral infection. The results showed 
that compared to control wells with no Artemisia 
draconculus, different concentrations of aqueous and 
hydroalcoholic extracts of Artemisia draconculus 
could not reduce viral plaques significantly (data not 
shown), however methanolic extracts of Eucalyptus 
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globulus had a significant inhibitory effect against 
HSV-1. Results of cytotoxicity assays showed that the 
CC50 of aqueous methanolic extracts of Eucalyptus 
globulus were 200 μg/mL, 150 μg/mL, 50 μg/mL 
respectively. When applied one hour before Vero 
cell infection with HSV-1, methanolic Eucalyptus 
globulus at the concentration of 200 μg/mL, 150 μg/mL, 
50 μg/mL caused a significant (P<0.05) reduction in 
viral plaques compared to the control samples (Figure 1; 
Figure 2). 
 
 
 
 
 
 
 
 
Figure 1 Incubation of cells with the Eucalyptus globulus 
extract before, during and after virus infection 
 
 
 
 
 
 
 
 
Figure 2 Effect of increasing concentration of Eucalyptus 
globulus and Artemisia draconculus extract and acyclovir on 
the titer of HSV-1 
 
2 Discussion 
Antiviral agents licensed currently for the treatment 
of herpes virus infections include acyclovir and 
derivatives, foscarnet and cidofovir, all of which 
inhibit herpes virus DNA polymerases (Khan et al., 
2005). Some of these antiviral agents might produce 
toxic side-effects. In addition, the emergence of virus 
strains resistant to commonly used anti-herpes virus 
drugs is of importance, particularly in Immunocom- 
promised patients (Ju et al., 2011). The development 
of viral resistance toward antiviral agents enhances 
the need for new effective compounds against viral 
infections. Thus, new antiviral agents exhibiting 
different mechanisms of action are urgently needed 
(Knickelbein et al., 2009). 
Medicinal plants produce a variety of chemical consti- 
tuents with the potential to inhibit viral replication and 
compounds from natural sources are of interest as 
possible sources to control viral infection (Koch et al., 
2008). These plants have been widely used to treat a 
variety of infectious and non-infectious diseases and 
represent an abundant source of new bioactive secon- 
dary metabolites. Thus plants continue to be a major 
source of new lead compounds (Batish et al., 2008). 
Besides small molecules from medicinal chemistry, 
natural products are still major sources of innovative 
therapeutic agents for various conditions, including 
infectious diseases (Wei and Shibamoto, 2010). 
In recent years, tendency of people for using 
traditional medication and medical plants have been 
arisen and even these remedies have been chosen as 
an alternative of industrialized medicine. 
Herpes virus is one of common factors to produce 
different diseases in human body. Complications of 
herpes virus such as blister, skin rash, and meningitis 
and brain encephalitis can be pointed out. 
According to acyclovir therapy against HSV virus, 
sometimes because of drug resistance or some 
restrictions in using industrialized drugs such as 
pregnancy, thinking about alternative therapies need to 
be felt. 
Eucalyptus globulus and Artemisia draconculus are 
two species of native herbs in Iran and the history of 
their usage goes back to many years ago. In different 
parts of Iran they can be found and their frequency is 
high, so they can be used as an alternative treatment. 
In this study the effects of two traditional herbs 
(Eucalyptus Globulus and Artemisia Draconculus) and 
acyclovir on herpes virus-1 were evaluated and 
their efficacy to suppress HSV-1 was reported. 
Based on results Eucalyptus globulus extract has 
more effects in different dilutions against HSV-1 in 
cell culture. According to our study, concentration 
(200 μg/mL, 150 μg/mL, 50 μg/mL) has the best 
effect and (>200 μg/mL) has lowest effect on HSV-1. 
About Artemisia draconculus, after varied examinations 
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in Vero cell line we could not find any inhibition 
effect against HSV-1 in different dilutions. 
To conclude, because of the widespread Eucalyptus 
globulus consumption in different countries especially 
in Iran, the extraction of this plant can be used as an 
alternative treatment. For drug production, air spray or 
a tropical ointment instead of industrialized drugs 
such as acyclovir would be suggested in many cases 
and of course in all of these studies, dose of herbs 
and the best way of consumption should be tested 
before using them to increase their positive effects in 
patients. 
3 Material and Methods 
3.1 Cell culture and Virus 
Vero cells (African green monkey kidney cells) were 
cultured with Dulbecco’s Modified Eagles’ Medium 
(DMEM) supplemented with 10% heat inactivated 
Fetal Bovine Serum (FBS), 100 IV/mL penicillin 
and l μg/mL streptomycin. The cells were maintained 
at 37℃ in a humidified atmosphere with 5% CO2 and 
were subculture two or three times a week. HSV-1 
was isolated from patients and identified by specific 
monoclonal antibodies. Viruses were quantified in 
terms of the 50% tissue culture infective dose 
(TCID50) by endpoint dilution, with the infectious 
titer determined by the method of Reed and Munch 
(14), and stored in small aliquots at -70℃ until use. 
3.2 Virus stock 
HSV-1 was isolated from the lip lesions of a patient 
and its genus was confirmed by neutralization test 
using guinea pig anti-HSV-1 serum and monoclonal 
anti-HSV-1 antibodies against HSV glycoprotein’s D 
and G. 
3.3 Plant materials  
Eucalyptus globulus and Artemisia draconculus were 
collected from a farmland in Kerman and identified at 
the department of Virology of Kerman university of 
Medical Sciences. The dried leaves were pulverized 
and 200 gr of pulverized sample was extracted with 
500 mL of 80% methanol by maceration for 72 h. The 
methanol extract was concentrated in a rotary evapo- 
rator, lyophilized and thereafter preserved for further 
use. Eucalyptus globulus and Artemisia draconculus 
stocks were prepared by dissolving 10 mg of each 
extract in one mL distilled water. It was then sterilized 
by filtration. 
For cytotoxicity and antiviral assays, the stock 
solutions of Eucalyptus globulus and Artemisia 
draconculus were diluted in the maintenance medium 
of Dulbecco’s modified Eagle’s growth medium 
(DMEM, Sigma) supplemented with 2% fetal bovine 
serum (Gibco, Germany), 0.14% (v/v) sodium bicar- 
bonate, 100 U/mL penicillin, 100 μg/mL streptomycin 
sulphate, and 0.25 μg/mL amphotericin B. 
3.4 Cytotoxicity assay 
In order to test the effect of the Eucalyptus globulus 
and Artemisia draconculus extract on vero cells, 5×l0
4
 
cells, (in l mL DMEM, supplemented with 10% FBS) 
were seeded in to each well of micro plates, cultured 
for 6 hr at 37℃, cells were allowed to grow for 
additional 48 h in the presence of increasing amounts 
of extract (10 μg/mL, 100 μg/mL, 200 μg/mL, 400 μg/mL, 
600 μg/mL, 800 μg/mL and 1 000 μg/mL), The 
cytotoxicity of the extract was determined on a 
conventional hemocytometer using the trypan blue 
exclusion method. The 50% cytotoxic concentration 
(CC50) was defined. As the concentration, which caused 
a 50% reduction in the number of viable cells. 
3.5 Incubation of cells with the extract before, 
during and after virus infection  
Eucalyptus Globulus and Artemisia draconculus 
hydroalcoholic extract was dissolved in serum free 
DMEM and incubated with semi-confluent cell in 24 
well tissue culture plates in increasing concentration 
from 10 to 1 000 μg/mL for 2 h at 37℃. After removal 
of the extract, the cells were washed with phosphate 
buffered saline (PBS) and then infected with HSV-1 at 
multiplicity of infection (MOI) 1. After l h incubation, 
the unabsorbed virus was removed, the cell monolayer 
was washed with PBS and further incubated in 
DMEM with 2% FBS. Controls consisted of Vero 
cells untreated and Vero cells infected with HSV1. 
For determination of antiviral activity of the extract 
during and post virus infection the assay was 
performed as described above, with the exception that 
the extract was added together with the virus and after 
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adsorption, correspondingly. After 48 h incubation at 
37℃ , virus titer was determined by the endpoint 
dilution method and expressed as TCID50 /mL. 
EC50, the concentration needed to restrain 50% virus 
infection compared to untreated infected cells, were 
determined directly from the curve obtained by 
plotting the inhibition of the virus yield against the 
concentration of the samples. 
3.6 Statistical analysis 
The mean number of viral plaques of two different 
experiments was compared with oneway analysis of 
variance (ANOVA) using SPSS v11.5. Dunnett test 
was used as the post hoc test. A P<0.05 was consi- 
dered statistically significant. 
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